New hope for kids battling Drug-Resistant HIV
NCT ID NCT04648280
Summary
This study is testing a drug called fostemsavir, combined with other optimized HIV medications, in children and adolescents (ages 6 to 18) whose current HIV treatments are failing because the virus has become resistant to multiple drugs. The main goals are to see if this new combination is safe, how the body processes the drug, and if it effectively lowers the amount of virus. It aims to provide a new treatment option for young people with very limited choices.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV INFECTIONS WITH MULTI DRUG RESISTANT VIRUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Children's Healthcare of Atlanta
Atlanta, Georgia, 30322, United States
-
FAM-CRU
Cape Town, South Africa
-
Hospital Federal dos Servidores do Estado
Rio de Janeiro, 20221-161, Brazil
-
Hospital Geral de Nova Iguaçu
Nova Iguaçu, Brazil
-
King Edward VIII Hospital
Durban, South Africa
-
PHRU
Soweto, South Africa
-
Rahima Moosa Mother and Child Hospital
Johannesburg, 2112, South Africa
-
Wits Reproductive Health and HIV Institutel
Johannesburg, South Africa
Conditions
Explore the condition pages connected to this study.